In this first episode of Inside the Author Studio: Behind the Scenes with the Guideline Authors, Dr. Jim Januzzi interviews guideline author Dr. Michelle Kittleson on patient-related issues and the changes in guideline classifications that will influence management. Listen to Dr. Kittleson provide some exciting developments in heart failure management regarding sodium-glucose co-transporter-2 inhibitors (SGLT2is).

This podcast is part of the Heart Failure & SGLT2is: The New Pillar in Care grant initiative.

Educational grant support is provided by Boehringer Ingelheim Pharmaceuticals Inc. (BIPI) and Lilly USA, LLC (Lilly). Click here for more.

Clinical Topics: Heart Failure and Cardiomyopathies, Acute Heart Failure, Cardiovascular Care Team

Keywords: CardiaCast, Heart Failure

< Back to Listings